International Journal Of Drug Regulatory Affairs
  • Year: 2026
  • Volume: 14
  • Issue: 2

Comparative Analysis of Cosmetic Labelling Requirements in the United States and Japan

  • Author:
  • Vaishnavi Ramesh Khandomalke1,*, Archana Yelmate1, Kranti Satpute1, Prakash Honrao1
  • Total Page Count: 4
  • Page Number: 90 to 93

1Dayanand Education Society’s, Dayanand College of Pharmacy, Latur-413512, Maharashtra, India

*Corresponding author. E-mail address: vaishnavikhandomalke@gmail.com (V.R. Khandomalke)

Abstract

Cosmetic labelling regulations serve as a fundamental mechanism to ensure consumer safety, transparency, and regulatory compliance. With the expansion of international cosmetic trade, manufacturers must comply with varying regulatory frameworks across different jurisdictions. In the United States, cosmetics are regulated by the US Food and Drug Administration under the Federal Food, Drug, and Cosmetic Act and the Fair Packaging and Labeling Act. In Japan, cosmetic products are governed by the Pharmaceuticals and Medical Devices Law administered by the Ministry of Health, Labour and Welfare. This review presents a structured comparative evaluation of cosmetic labelling requirements in both countries, focusing on mandatory label elements, ingredient declaration systems, language obligations, claims regulation, warning statements, and enforcement mechanisms. The analysis identifies major similarities and regulatory differences that impact global market entry strategies.

Although both regulatory systems aim to protect consumer health, the United States follows a manufacturer-responsibility and post-market surveillance model, whereas Japan adopts a more prescriptive and language-specific regulatory structure. Understanding these distinctions is essential for regulatory compliance and successful international marketing.

Keywords

Cosmetics, Labelling, USFDA, MHLW, Regulatory Affairs, Comparative Review